Warning: The NCBI web site requires JavaScript to function. more...
Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling.
Boileau C, Tat SK, Pelletier JP, Cheng S, Martel-Pelletier J.
Arthritis Res Ther. 2008;10(3):R71. Epub 2008 Jun 25.
Related citations
Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
Pelletier JP, Lajeunesse D, Reboul P, Mineau F, Fernandes JC, Sabouret P, Martel-Pelletier J.
J Rheumatol. 2001 Apr;28(4):814-24.
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J.
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304.
Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts.
Amiable N, Tat SK, Lajeunesse D, Duval N, Pelletier JP, Martel-Pelletier J, Boileau C.
Bone. 2009 Jun;44(6):1143-50. Epub 2009 Mar 2.
Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage.
Moldovan F, Pelletier JP, Jolicoeur FC, Cloutier JM, Martel-Pelletier J.
Osteoarthritis Cartilage. 2000 May;8(3):186-96.
Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures.
Yaron M, Shirazi I, Yaron I.
Osteoarthritis Cartilage. 1999 May;7(3):272-80.
The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.
Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, Rodan GA, Duong le T.
Arthritis Rheum. 2004 Apr;50(4):1193-206.
Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
Pelletier JP, Lajeunesse D, Jovanovic DV, Lascau-Coman V, Jolicoeur FC, Hilal G, Fernandes JC, Martel-Pelletier J.
J Rheumatol. 2000 Dec;27(12):2893-902.
The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K.
Pelletier JP, Boileau C, Brunet J, Boily M, Lajeunesse D, Reboul P, Laufer S, Martel-Pelletier J.
Bone. 2004 Mar;34(3):527-38.
Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis.
Domagala F, Martin G, Bogdanowicz P, Ficheux H, Pujol JP.
Biorheology. 2006;43(3-4):577-87.
Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes.
Tamura T, Kosaka N, Ishiwa J, Sato T, Nagase H, Ito A.
Osteoarthritis Cartilage. 2001 Apr;9(3):257-63.
Osteoarthritic cartilage chondrocytes alter subchondral bone osteoblast differentiation via MAPK signalling pathway involving ERK1/2.
Prasadam I, Friis T, Shi W, van Gennip S, Crawford R, Xiao Y.
Bone. 2010 Jan;46(1):226-35. Epub 2009 Oct 22.
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK, Pelletier JP, Mineau F, Caron J, Martel-Pelletier J.
Bone. 2011 Sep;49(3):559-67. Epub 2011 Jun 12.
Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase.
Pelletier JP, Mineau F, Boileau C, Martel-Pelletier J.
Clin Exp Rheumatol. 2003 Mar-Apr;21(2):171-7.
Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1.
Felisaz N, Boumediene K, Ghayor C, Herrouin JF, Bogdanowicz P, Galerra P, Pujol JP.
Osteoarthritis Cartilage. 1999 May;7(3):255-64.
The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
Hwa SY, Burkhardt D, Little C, Ghosh P.
J Rheumatol. 2001 Apr;28(4):825-34.
Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
J Cell Physiol. 2009 Dec;221(3):618-28.
Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways.
Legendre F, Bogdanowicz P, Martin G, Domagala F, Leclercq S, Pujol JP, Ficheux H.
Clin Exp Rheumatol. 2007 Jul-Aug;25(4):546-55.
Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J.
Arthritis Rheum. 2008 Dec;58(12):3820-30.
Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes.
Alvarez-Soria MA, Herrero-Beaumont G, Sánchez-Pernaute O, Bellido M, Largo R.
Rheumatology (Oxford). 2008 May;47(5):627-33. Epub 2008 Mar 27.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on